Anti C5 Complement mAb Placebo, Ultomiris 1,100 mg/11 mL concentrate for solution for infusion
ALXN1210-IgAN-320
Phase 3 small_molecule active
Quick answer
Anti C5 Complement mAb Placebo, Ultomiris 1,100 mg/11 mL concentrate for solution for infusion for Immunoglobulin A Nephropathy (IgAN) is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Immunoglobulin A Nephropathy (IgAN)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active